| For: | Choden T, Mandaliya R, Charabaty A, Mattar MC. Monitoring inflammatory bowel disease during pregnancy: Current literature and future challenges. World J Gastrointest Pharmacol Ther 2018; 9(1): 1-7 [PMID: 29430322 DOI: 10.4292/wjgpt.v9.i1.1] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5349/full/v9/i1/1.htm |
| Number | Citing Articles |
| 1 |
Mousa Ayoub, Anna Muzalyova, Alanna Ebigbo, Sandra Nagl, Christoph Römmele, Johanna Classen, Julia Wanzl, Carola Fleischmann, Sami Ayoub, Vidan Tadic, Jakob Schlottmann, Elisabeth Schnoy. Pregnancy in Inflammatory Bowel Disease: Data from a Real-World Cohort in Germany. Journal of Clinical Medicine 2024; 13(24) doi: 10.3390/jcm13247710
|
| 2 |
L. L. H. Peeters, P. W. de Leeuw, E. D. Post Uiterweer. Pathophysiology of pregnancy complications. 2021; doi: 10.1007/978-90-368-2571-9_4
|
| 3 |
Michael Udegbune, Hayley Sharrod–Cole, Sarah Townsend, Ben Allen, Matthew J Brookes, Clare Ford, Rousseau Gama. Diagnostic performance of serum calprotectin in discriminating active from inactive ulcerative colitis in an outpatient setting. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 2022; 59(6) doi: 10.1177/00045632221116830
|
| 4 |
I. V. Oleksiienko, I. V. Prolygina, О. L. Lovkina, L. A. Klimas, S. A. Tarasiuk, S. V. Prokopenko, S. I. Semenenko. Profiles of neutrophilic intestinal inflammation and endothelial dysfunction in patients with inflammatory bowel disease. Reports of Vinnytsia National Medical University 2025; 29(1) doi: 10.31393/reports-vnmedical-2025-29(1)-11
|
| 5 |
Amihai Rottenstreich, Tali Mishael, Sorina Grisaru Granovsky, Benjamin Koslowsky, Hagai Schweistein, Guila Abitbol, Eran Goldin, Ariella Bar-Gil Shitrit. Clinical utility of fecal calprotectin in monitoring disease activity and predicting relapse in pregnant patients with inflammatory bowel diseases. European Journal of Internal Medicine 2020; 77 doi: 10.1016/j.ejim.2020.03.015
|
| 6 |
Reem Al-jabri, Panu Wetwittayakhlang, Peter L. Lakatos. Monitoring of Inflammatory Bowel Disease in Pregnancy: A Review of the Different Modalities. Journal of Clinical Medicine 2023; 12(23) doi: 10.3390/jcm12237343
|
| 7 |
Nahla A. Azzam, Abdulelah Almutairdi, Hajer Y. Almudaiheem, Turki AlAmeel, Shakir A. Bakkari, Othman R. Alharbi, Khalidah A. Alenzi, Maha A. AlMolaiki, Bedor A. Al-Omari, Rayan G. Albarakati, Ahmed H. Al-Jedai, Omar I. Saadah, Majid A. Almadi, Badr Al-Bawardy, Mahmoud H. Mosli. Saudi consensus guidance for the management of inflammatory bowel disease during pregnancy. Saudi Journal of Gastroenterology 2023; doi: 10.4103/sjg.sjg_318_23
|
| 8 |
Ralley E. Prentice, Emma K. Flanagan, Emily K. Wright, Michael T. Dolinger, Zoe Gottlieb, Alyson L. Ross, Megan Burns, Danny Con, Edward Shelton, Ray Boyapati, Ilyra Aronsky, Gregory T. Moore, William Connell, Miles P. Sparrow, Peter De Cruz, Michael A. Kamm, Ilana Prideaux, Rimma Goldberg, Katerina V. Kiburg, Marla C. Dubinsky, Sally J. Bell. Active Inflammatory Bowel Disease on Intestinal Ultrasound During Pregnancy Is Associated With an Increased Risk of Adverse Pregnancy and Neonatal Outcomes Independent of Clinical and Biochemical Disease Activity. Gastroenterology 2025; 169(4) doi: 10.1053/j.gastro.2025.03.016
|
| 9 |
Amihai Rottenstreich, Maayan Diminsky, Sorina Grisaru Granovsky, Tali Mishael, Batia Roth, Galia Spectre, Yosef Kalish, Eran Goldin, Ariella Bar-Gil Shitrit. Assessment of the procoagulant potential and associated risk factors in pregnant patients with inflammatory bowel diseases. European Journal of Internal Medicine 2019; 65 doi: 10.1016/j.ejim.2019.04.013
|
| 10 |
James M. Gray, Kristin Knight, Vu Q. Nguyen, Marrieth G. Rubio, Lauren Irby, James H. Boone, Dario Sorrentino. Fecal Lactoferrin and Other Stool Markers during Normal Pregnancy and in Inflammatory Bowel Diseases: A Prospective Study and Review of the Literature. Inflammatory Intestinal Diseases 2020; 5(3) doi: 10.1159/000508970
|
| 11 |
Nariman Hossein-Javaheri, Michael Youssef, Yaanu Jeyakumar, Vivian Huang, Parul Tandon. The Management of Inflammatory Bowel Disease during Reproductive Years: An Updated Narrative Review. Reproductive Medicine 2023; 4(3) doi: 10.3390/reprodmed4030017
|
| 12 |
Günther A. Rezniczek, Claudia Förster, Ziad Hilal, Timm Westhoff, Clemens B. Tempfer. Calprotectin in pregnancy and pregnancy-associated diseases: a systematic review and prospective cohort study. Archives of Gynecology and Obstetrics 2019; 299(6) doi: 10.1007/s00404-019-05134-8
|
| 13 |
Richard Y. Wu, Parul Tandon, Lindsy Ambrosio, Garett Dunsmore, Naomi Hotte, Levinus A. Dieleman, Shokrollah Elahi, Karen Madsen, Vivian Huang. Post-neonatal Outcomes of Infants Born to Women with Active Trimester One Inflammatory Bowel Disease: A Pilot Study. Digestive Diseases and Sciences 2022; 67(11) doi: 10.1007/s10620-022-07430-x
|
| 14 |
Laura C. Sahyoun, Jill K. J. Gaidos. A Practical Approach to IBD Care in the Pregnant Patient. Current Gastroenterology Reports 2022; 24(12) doi: 10.1007/s11894-022-00856-3
|
| 15 |
Shiqing Zhao, Shengpu Zhou, Junmei Wang, Yanyan Shi. When inflammatory bowel disease meets pregnancy. European Journal of Internal Medicine 2025; 140 doi: 10.1016/j.ejim.2025.06.014
|